Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed375%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
terminated

Evaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502

NCT03609021
completed

Breast Disease and Cardiovascular Disease

NCT03779217
completednot_applicable

Inpatient Screening Mammography for Non-adherent and High Risk Women

NCT04164251
completednot_applicable

Molecular Breast Imaging in Women With Atypia and LCIS

NCT00620087

Clinical Trials (4)

Showing 4 of 4 trials
NCT03609021

Evaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502

Terminated
NCT03779217

Breast Disease and Cardiovascular Disease

Completed
NCT04164251Not Applicable

Inpatient Screening Mammography for Non-adherent and High Risk Women

Completed
NCT00620087Not Applicable

Molecular Breast Imaging in Women With Atypia and LCIS

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4